International Clinical Trial: A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta(R), and to Evaluate Safety in Healthy Adult Male Volunteers

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131972) titled 'A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta(R), and to Evaluate Safety in Healthy Adult Male Volunteers' on Sept. 8.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: Hopeshine-Minsheng Hos pital of Xinzheng

Condition: Neutropenia

Intervention: Sequence 1:Cycle 1: NKF-PEG Cycle 2: US-Neulasta Sequence 2:Cycle 1: US-Neulasta

Recruitment Status: Recruiting

Phase: 1

Date of First Enrollment: 2026-07-21

Target Sample Size: Sequence 1:101;Sequenc...